Biosight’s Merger with Advaxis

Horn & Co. advised Biosight Ltd. in the transaction.

Biosight Ltd. signed a merger agreement with Advaxis, Inc, a clinical-stage biotechnology company. 

BioSight is a pharmaceutical development company, developing novel cancer-targeted drugs.

The Horn & Co team was led by Yuval Horn (Picture), Assaf Unger and Ana Eiskov.

Involved fees earner: Ana Eiskov – Horn & Co. Law; Yuval Horn – Horn & Co. Law; Assaf Unger – Horn & Co. Law;

Law Firms: Horn & Co. Law;

Clients: Biosight, Ltd;

Leave a Reply